Skip to search.
 STI Down 0.61%

ANI Pharmaceuticals, Inc. (ANIP)

-NasdaqGM
66.14 Down 4.12(5.86%) 28 Apr 04:00 SGT
Add to Portfolio
Prev Close:70.26
Open:70.30
Bid:66.00 x 100
Ask:86.00 x 600
1y Target Est:75.33
Beta:3.79
Earnings Date:4 May - 8 May (Est.)
Day's Range:65.75 - 70.79
52wk Range:24.24 - 72.61
Volume:203,756
Avg Vol (3m):328,074
Market Cap:753.20M
P/E (ttm):25.54
EPS (ttm):2.59
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
ANIPDown 5.86%753.20M
GSKUp 0.56%112.70B

Key Statistics

Forward P/E (1 yr):16.79
P/S (ttm):14.30
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :2.79
Quarterly EPS Est (Mar-15) :0.56
Mean Recommendation*:1.7
PEG Ratio (5 yr expected):1.18

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

ANI Pharmaceuticals, Inc., an integrated specialty pharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback